QA: CATALYST PHARMACEUTICALS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001369568_2023_CATALYST_PHARMACEUTICALS_INC.pdf

Logs

Graph

Absolute values for 0001369568, CATALYST PHARMACEUTICALS INC.

  xvar xval
0 AssetsCurrent 320,797,000
1 IntangibleAssetsNetIncludingGoodwill 32,471,000
2 PropertyPlantAndEquipmentNet 847,000
3 remainder_Assets 21,515,000
4 LiabilitiesCurrent 57,588,000
5 LiabilitiesNoncurrent 17,621,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 34,393,000
8 SellingGeneralAndAdministrativeExpense 58,183,000
9 ResearchAndDevelopmentExpense 19,789,000
10 remainder_Expenses 21,640,000
11 remainder_Revenues 214,203,000
12 remainder_NetIncome 2,881,000
13 remainder_ComprehensiveNetIncome 172,000
  yvar yval
0 Assets 375,630,000
1 Liabilities 75,209,000
2 Expenses 134,005,000
3 Revenues 214,203,000
4 StockholdersEquity 300,421,000
5 NetIncome 83,079,000
6 ComprehensiveNetIncome 83,165,000
7 BaseVar 401,050,000
8 EconomicCapitalRatio 2.66

Edgar->Model Mapping

Feature Distribution

Change over Time